So-Young International Inc. (SY) |
|
1.02 0.01 (0.99%)
|
05-16 07:51 |
|
Open: |
1.02 |
Pre. Close: |
1.01 |
|
High:
|
1.06 |
Low:
|
0.9907 |
|
Volume:
|
1,075,934 |
Market Cap:
|
112(M) |
|
|
|
|
So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment in the People's Republic of China and internationally. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment. As of December 31, 2020, it had approximately 6,900 medical aesthetic service providers and 4,200 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China.So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment in the People's Republic of China and internationally. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment. As of December 31, 2020, it had approximately 6,900 medical aesthetic service providers and 4,200 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.06 - 1.07 |
1.07 - 1.07 |
|
Low:
|
0.98 - 0.98 |
0.98 - 0.99 |
|
Close:
|
1.01 - 1.02 |
1.02 - 1.03 |
|
Technical analysis |
as of: 2022-05-13 4:41:42 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 1.86  One year: 2.31 |
| Support: |
Support1: 0.97 Support2: 0.81 |
| Resistance: |
Resistance1: 1.6 Resistance2: 1.98 |
| Pivot: |
1.28 |
| Moving Average: |
MA(5): 1.07 MA(20): 1.34
MA(100): 2.19 MA(250): 4.56 |
| MACD: |
MACD(12,26): -0.3 Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 4.8  %D(3): 5.6 |
| RSI: |
RSI(14): 24.5 |
| 52-week: |
High: 11 Low: 0.97 |
| Average Vol(K): |
3-Month: 620 (K) 10-Days: 871 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SY ] has closed above bottom band by 10.3%. Bollinger Bands are 13.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 16 May 2022
Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update - BioSpace
Sun, 15 May 2022
The Takedown Review: Omar Sy Stars in the French-language Sequel to “On the Other Side of the Tracks.” - The Shahab
Sat, 14 May 2022
Prolific Author of Animal Books Sy Montgomery Discusses her Foray into Falconry - WMNF
Thu, 12 May 2022
Wordle Game Help: 5-letter words ending with 'SY' - Dot Esports
Thu, 12 May 2022
5-Letter Words Ending with SY - GameRant
Wed, 11 May 2022
Author Sy Montgomery talks hawks; Craig McNamara's 'Because Our Fathers Lied' : Here & Now - NPR
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Health Information Services |
| Shares Out. |
105 (M) |
| Shares Float |
27 (M) |
|
% Held by Insiders
|
39.3 (%) |
|
% Held by Institutions
|
53.8 (%) |
|
Shares Short
|
3,420 (K) |
|
Shares Short P.Month
|
3,300 (K) |
Stock Financials |
|
EPS
|
0.05 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
23.28 |
|
Profit Margin (%)
|
3.4 |
|
Operating Margin (%)
|
2.7 |
|
Return on Assets (ttm)
|
0.8 |
|
Return on Equity (ttm)
|
2 |
|
Qtrly Rev. Growth
|
20 |
|
Gross Profit (p.s.)
|
10.29 |
|
Sales Per Share
|
15.92 |
|
EBITDA (p.s.)
|
0.63 |
|
Qtrly Earnings Growth
|
698.7 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
20 |
|
PEG Ratio
|
5.6 |
|
Price to Book value
|
0.04 |
|
Price to Sales
|
0.06 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
